(FM) Hematología
Departamento académico
Rush University Medical Center
Chicago, Estados UnidosPublications en collaboration avec des chercheurs de Rush University Medical Center (4)
2022
-
Melphalan flufenamide for relapsed/refractory multiple myeloma
Drugs of today (Barcelona, Spain : 1998), Vol. 58, Núm. 8, pp. 407-423
-
Patient-reported outcomes in relapsed/refractory multiple myeloma treated with melflufen plus dexamethasone: analyses from the Phase II HORIZON study
British Journal of Haematology, Vol. 196, Núm. 3, pp. 639-648
2021
-
Melflufen and Dexamethasone in Heavily Pretreated Relapsed and Refractory Multiple Myeloma
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 39, Núm. 7, pp. 757-767
2020
-
Melflufen for relapsed and refractory multiple myeloma
Expert Opinion on Investigational Drugs, Vol. 29, Núm. 10, pp. 1069-1078